CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Eribulin mesylate 1.4 mg/m^2 intravenous - Phase 3 | ESALY Pipeline | CatalystAlert